[HTML][HTML] The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update

M Merhi, F Ahmad, N Taib, V Inchakalody… - Seminars in Cancer …, 2023 - Elsevier
Cancer immunity is regulated by several mechanisms that include co-stimulatory and/or co-
inhibitory molecules known as immune checkpoints expressed by the immune cells. In …

Hyperthermia in combination with emerging targeted and immunotherapies as a new approach in cancer treatment

T Logghe, E van Zwol, B Immordino, K Van den Cruys… - Cancers, 2024 - mdpi.com
Simple Summary This manuscript discusses the ongoing challenge of cancer as a leading
global cause of death despite advancements in therapies. It highlights the role of …

Signaling, cancer cell plasticity, and intratumor heterogeneity

M Cordani, I Dando, G Ambrosini… - Cell Communication and …, 2024 - Springer
Cancer's complexity is in part due to the presence of intratumor heterogeneity and the
dynamic nature of cancer cell plasticity, which create substantial obstacles in effective …

Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells

J Wu, W Li, J Su, J Zheng, Y Liang, J Lin, B Xu… - Scientific Reports, 2024 - nature.com
The prognosis for patients with colorectal cancer (CRC) remains worse than expected due to
metastasis, recurrence, and resistance to chemotherapy. Colorectal cancer stem cells …

Unmasking the deceptive nature of cancer stem cells: the role of CD133 in revealing their secrets

J Pospieszna, H Dams-Kozlowska, W Udomsak… - International Journal of …, 2023 - mdpi.com
Cancer remains a leading cause of death globally, and its complexity poses a significant
challenge to effective treatment. Cancer stem cells and their markers have become key …

Molecular biomarkers and signaling pathways of cancer stem cells in colorectal cancer

MM Omran, MS Fouda, SA Mekkawy… - … in Cancer Research …, 2024 - journals.sagepub.com
Colorectal cancer (CRC) is the third most frequently found cancer in the world, and it is
frequently discovered when it is already far along in its development. About 20% of cases of …

Ligands of CD6: Roles in the pathogenesis and treatment of cancer

M Gurrea-Rubio, F Lin, MS Wicha… - Frontiers in …, 2025 - frontiersin.org
Cluster of Differentiation 6 (CD6), an established marker of T cells, has multiple and complex
functions in regulation of T cell activation and proliferation, and in adhesion of T cells to …

Extracellular vesicle membrane protein profiling and targeted mass spectrometry unveil CD59 and tetraspanin 9 as novel plasma biomarkers for detection of colorectal …

S Dash, CC Wu, CC Wu, SF Chiang, YT Lu, CY Yeh… - Cancers, 2022 - mdpi.com
Simple Summary It is well recognized that EVs carry many membrane proteins on their
surface that can transduce signals to recipient cells and serve as biomarkers/target proteins …

Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage …

G Cui, Z Wang, H Liu, Z Pang - Frontiers in Immunology, 2022 - frontiersin.org
The majority of colorectal cancers (CRCs) are thought to arise from precancerous
adenomas. Upon exposure to diverse microenvironmental factors, precancerous stem cells …

Roles of miRNAs in regulating ovarian cancer stemness

C Zhi-**ong - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate.
Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased …